Mebeverine is a musculotropic antispasmodic agent primarily utilized to treat symptoms associated with irritable bowel syndrome, such as spastic colitis, chronic irritable colon, and other gastrointestinal… Read more














Mebeverine is a musculotropic antispasmodic agent primarily utilized to treat symptoms associated with irritable bowel syndrome, such as spastic colitis, chronic irritable colon, and other gastrointestinal motility disorders. By relaxing smooth muscle within the gut without impacting cardiac activity or inducing sedation, it effectively manages abdominal pain and cramping. This category provides essential reference standards for Mebeverine, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These high-quality materials are critical for laboratories performing rigorous impurity profiling, analytical method validation, and routine quality control. The collection features specific degradation products formed via hydrolysis or oxidation, alongside stable isotope-labelled analogues designed for use as internal standards in mass spectrometry. Pharmaceutical researchers rely on these qualified compounds to ensure compliance with regulatory standards and to accurately characterize the drug’s stability and safety profile throughout analytical testing.